Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lokon Pharma Ab

Clinical trials sponsored by Lokon Pharma Ab, explained in plain language.

Cold virus weaponized to fight pancreatic cancer in early trial

Disease control Completed

This early-stage trial tested the safety of a new treatment called LOAd703 for pancreatic cancer. LOAd703 is a modified common cold virus designed to infect and kill cancer cells while also boosting the body's immune system. The study involved 51 patients who received the virus a…

Phase: PHASE1, PHASE2 • Sponsor: Lokon Pharma AB • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC